KPKeun-Hong Park

Keun-Hong Park

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Keun-Hong Park has a total of 128 co-authors. Here are the top co-authors by number of shared publications:

  • Ji Sun Park

    Department of Biomedical Science, College of Life Science, CHA University, 6F, CHA Biocomplex, Sampyeong-Dong, Bundang-gu, Seongnam-si 13488, Republic of Korea

    30 shared publications
  • Hye Jin Kim

    Department of Biomedical Science, CHA University, Seongnam-si, Republic of Korea

    25 shared publications
  • Han Na Yang

    Department of Biomedical Science, College of Life Science, CHA University, 6F, CHA Bio-complex, Sampyeong-Dong, Bundang-gu, Seongam-si, Republic of Korea

    16 shared publications
  • Hui Bang Cho

    Laboratory of Nano-regenerative Medicine, Department of Biomedical Science, College of Life Science, CHA University, CHA Biocomplex, Sampyeong-Dong, Bundang-gu, Seongnam-si, 13488, Republic of Korea

    16 shared publications
  • Se Won Yi

    Laboratory of Nano-regenerative Medical Engineering, Department of Biomedical Science, College of Life Science, CHA University, 618, CHA Biocomplex, Sampyeong-Dong, Bundang-gu, Seongnam-si, 13488, Republic of Korea.

    16 shared publications
  • Dae Gyun Woo

    CHA Advanced Research Institute, 7F, CHA Biocomplex, Sampyeong-Dong, Bundang-gu, Seongnam-si, 13488, Republic of Korea

    12 shared publications

Latest Publications

  • Open Access

    Tumor-targeted liposomal RNAi therapy suppresses breast cancer and modulates tumor microenvironment

    by Sujeong Lee, Seung Hee Choi, Hui Bang Cho, Chae Won Cho, Jungsun Lee, Gyuwon So, Hye Jin Kim, Kyung-Soon Park, Keun-Hong Park

    Liposomes are widely used nanocarriers, but their clinical translation remains limited by poor tumor selectivity and inefficient nucleic acid delivery. To address these challenges, we designed multifunctional liposomes incorporating phenylboronic acid (PBA) for tumor targeting, ginsenoside Rh2 (Rh2) as both a cholesterol-mimetic stabilizer and intrinsic anticancer agent, and small interfering RNA against vascular endothelial growth factor (VEGF). VEGF was selected for its pivotal role in tumor angiogenesis and to counteract the paradoxical pro-angiogenic effect of Rh2. PBA-modified liposomes exhibited enhanced tumor accumulation and cellular uptake compared with non-targeted controls. Rh2 induced direct cytotoxicity, while VEGF silencing further suppressed angiogenesis together producing synergistic antitumor activity. In vivo, Rh2-PBA-siVEGF liposomes (RhPLIPO-siVEGF) and Rh2-PBA-Negative Control siRNA (siNC) liposomes (RhPLIPO-siNC) were evaluated in a 4T1 orthotopic breast tumor model. Both formulations elicited effects characterized by increased infiltration of T cells and M1 macrophages. Notably, RhPLIPO-siVEGF treatment significantly reduced tumor growth and microvascular density compared with RhPLIPO-siNC, confirming synergy between Rh2-mediated cytotoxicity and VEGF knockdown. Overall, this multifunctional liposomal system integrates tumor targeting, intrinsic cytotoxicity, and RNA interference-mediated anti-angiogenesis with minimal adverse effects, offering a potent and versatile nanoplatform for targeted breast cancer therapy.

  • Open Access

    Orally delivered, pH-resistant dual coated extracellular vesicles restore intestinal barrier function and suppress colitis

    by Chae Won Cho, Jaewon Roh, Sujeong Lee, Hui Bang Cho, Jungsun Lee, Gyuwon So, Kun Na, Hye Jin Kim, Keun-Hong Park


  • Open Access

    Near Infrared‐Mediated Intracellular NADH Delivery Strengthens Mitochondrial Function and Stability in Muscle Dysfunction Model

    by Hui Bang Cho, Hye‐Ryoung Kim, Sujeong Lee, Chae Won Cho, Ji‐In Park, Seulki Youn, Gyuwon So, Sumin Kang, Hye Jin Kim, Keun‐Hong Park

    Mitochondrial transfer emerges as a promising therapy for the restoration of mitochondrial function in damaged cells, mainly due to its limited immunogenicity. However, isolated mitochondria rapidly lose function because they produce little energy outside cells. Therefore, this study investigates whether near infrared (NIR)‐mediated nicotinamide adenine dinucleotide (NADH) pre‐treatment enhances mitochondrial function and stability in mitochondria‐donor cells prior to transplantation. Clinical applications of NADH, an essential electron donor in the oxidative phosphorylation process, are restricted due to the limited cellular uptake of NADH. To address this, a photo‐mediated method optimizes direct NADH delivery into cells and increases NADH absorption. L6 cells treated with NADH and irradiated with NIR enhanced NADH uptake, significantly improving mitochondrial energy production and function. Importantly, the improved functional characteristics of the mitochondria are maintained even after isolation from cells. Primed mitochondria, i.e., those enhanced by NIR‐mediated NADH uptake (P‐MT), are encapsulated in fusogenic liposomes and delivered into muscle cells with mitochondrial dysfunction. Compared to conventional mitochondria, P‐MT mitochondria promote greater mitochondrial recovery and muscle regeneration. These findings suggest that NIR‐mediated NADH delivery is an effective strategy for improving mitochondrial function, and has the potential to lead to novel treatments for mitochondrial disorders and muscle degeneration.


  • Open Access

    Osteoblast‐Derived Mitochondria Formulated with Cationic Liposome Guide Mesenchymal Stem Cells into Osteogenic Differentiation

    by Hye‐Ryoung Kim, Seonjeong Woo, Hui Bang Cho, Sujeong Lee, Chae Won Cho, Ji‐In Park, Seulki Youn, Gyuwon So, Sumin Kang, Sohyun Hwang, et al.

    While mitochondria are known to be essential for intracellular energy production and overall function, emerging evidence highlights their role in influencing cell behavior through mitochondrial transfer. This phenomenon provides a potential basis for the development of treatment strategies for tissue damage and degeneration. This study aims to evaluate whether mitochondria isolated from osteoblasts can promote osteogenic differentiation in mesenchymal stem cells (MSCs). Mitochondria from MSCs, which primarily utilize glycolysis, are compared with those from MG63 cells, which depend on oxidative phosphorylation. Mitochondria from both cell types are then encapsulated in cationic liposomes and transferred to MSCs, and their impact on differentiation is assessed. Mitochondria delivery from MG63 cells to MSCs grown in both two‐ and three‐dimensional cultures results in increased expression of osteogenic markers, including Runt‐related transcription factor 2, Osterix, and Osteopontin, and upregulation of genes involved in Bone morphogenetic protein 2 signaling and calcium import. This is accompanied by increased calcium influx and regulated by the Wnt/β‐catenin signaling pathway. Transplantation of spheroids containing MSCs with MG63‐derived mitochondria in bone defect animal models improves bone regeneration. The results suggest that delivery of MG63‐derived mitochondria effectively guides MSCs toward osteogenesis, paving the way for the development of mitochondria‐transplantation therapies.


  • Open Access

    Light emitting diode (LED) irradiation of liposomes enhances drug encapsulation and delivery for improved cancer eradication

    by Sujeong Lee, Jin-Ho Choi, Hye Jung Jang, Hui Bang Cho, Hye-Ryoung Kim, Ji-In Park, Kyung-Soon Park, Keun-Hong Park


  • Nano-chemical priming strategy to enhance TGF-β resistance and anti-tumor activity of natural killer cells

    by Seung Hee Choi, Hui Bang Cho, Jin-Ho Choi, Hye Jin Kim, Hye Jung Jang, Seohyun Cho, Eunchong Maeng, Hail Park, Ki Seo Ryu, Keun-Hong Park, et al.


  • Open Access

    Upconverting-photon quenching-mediated perforation influx as an intracellular delivery method using posAuNP@UCNPs nanocomposites for osteoarthritis treatment

    by Hye Jin Kim, Hui Bang Cho, Hye-Ryoung Kim, Sujeong Lee, Ji-In Park, Keun-Hong Park

    Photoporation techniques based on plasmonic nanoparticles such as gold nanoparticles have been extensively studied for the intracellular delivery of substances via cell membrane disruption. However, the clinical application of AuNP is challenging due to its absorption in the 500 nm region of the light spectrum. To overcome this challenge, upconversion nanoparticles were employed to stimulate AuNP at NIR wavelengths. posAuNP@UCNPs nanocomposites were produced by coating 30 nm UCNPs on 80 nm AuNPs using DOPA-PEI, which were then irradiated with 980 nm NIR light to facilitate their intracellular delivery. TEM and DLS confirmed that posAuNP and UCNP combine to form nanocomposites. Additionally, multiphysics simulation was used to analyze the distribution of the posAuNP electric field based on morphological differences that change as the UCNP ratio increases. Next, effective LED irradiation conditions were established by applying upconverting-photon quenching-mediated perforation influx to C28/I2 cells as suspensions or spheroids. posAuNP@UCNP nanocomposites were confirmed to be effective for the delivery of baricitinib as a treatment for osteoarthritis in a three-dimensional osteoarthritis model. Finally, chondrocyte differentiation was induced through intracellular delivery of baricitinib using posAuNP@UCNPs. The findings suggest that posAuNP@UCNPs have great potential as a tool for non-invasive drug delivery via UCPPin. Graphical Abstract


  • Open Access

    Fusogenic liposomes encapsulating mitochondria as a promising delivery system for osteoarthritis therapy

    by Hye-Ryoung Kim, Hui Bang Cho, Sujeong Lee, Ji-In Park, Hye Jin Kim, Keun-Hong Park


  • Open Access

    Upconverting-photon Quenching-mediated Perforation Influx as an Intracellular Delivery Method using posAuNP@UCNPs Nanocomposites for Osteoarthritis Treatment

    by Hui Bang Cho, Hye-Ryoung Kim, Sujeong Lee, Ji-In Park, Keun-Hong Park

    Photoporation techniques based on plasmonic nanoparticles such as gold nanoparticles have been extensively studied for the intracellular delivery of substances via cell membrane disruption. However, the clinical application of AuNP is challenging due to its absorption in the 500 nm region of the light spectrum. To overcome this challenge, upconversion nanoparticles were employed to stimulate AuNP at NIR wavelengths. posAuNP@UCNPs nanocomposites were produced by coating 30 nm UCNPs on 80 nm AuNPs using DOPA-PEI, which were then irradiated with 980 nm NIR light to facilitate their intracellular delivery. TEM and DLS confirmed that posAuNP and UCNP combine to form nanocomposites. Additionally, multiphysics simulation was used to analyze the distribution of the posAuNP electric field based on morphological differences that change as the UCNP ratio increases. Next, effective LED irradiation conditions were established by applying upconverting-photon quenching-mediated perforation influx to C28/I2 cells as suspensions or spheroids. posAuNP@UCNP nanocomposites were confirmed to be effective for the delivery of baricitinib as a treatment for osteoarthritis in a three-dimensional osteoarthritis model. Finally, chondrocyte differentiation was induced through intracellular delivery of baricitinib using posAuNP@UCNPs. The findings suggest that posAuNP@UCNPs have great potential as a tool for non-invasive drug delivery via UCPPin.

  • Open Access

    Reduction of nanoparticle size and promotion of cell membrane permeability by LED irradiation

    by Hui Bang Cho, Hye Jin Kim, Sujin Lee, Hye-Ryoung Kim, Sujeong Lee, Ji-In Park, Keun-Hong Park